BioMed Research International / 2009 / Article / Fig 1

Research Article

OXavidin for Tissue Targeting Biotinylated Therapeutics

Figure 1

Diffusion kinetic of 125I-labeled avidin or streptavidin injected in a limb and distribution in blood, liver, and kidney. At indicated time points, mice were sacrificed and tissue samples weighted and counted in a gamma-counter. Data are expressed as % ID/100 mg of tissue. Each point is the average of 5 mice. Bars represent standard deviation.
921434.fig.001a
(a)
921434.fig.001b
(b)
921434.fig.001c
(c)
921434.fig.001d
(d)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.